This is an RSS newsfeed from BioMed Central It is intended to be used with an RSS reader. For more information about RSS newsfeeds from BioMed Central, visit http://www.biomedcentral.com/info/about/rss/ Current Opinion in Investigational Drugs - Latest articles http://thomsoncurrentdrugs.com/products/journals/coid The latest articles from Current Opinion in Investigational Drugs (ISSN 1472-4472) published by Current Drugs Limited. AL-108 and AL-208, formulations of the neuroprotective NAP fragment of activity-dependent neuroprotective protein, for cognitive disorders http://www.biomedcentral.com/1472-4472/9/800 H Geerts Current Opinion in Investigational Drugs 2008, 9:800-811 2008-07-01 doi:10.1186/cd-921661 Current Opinion in Investigational Drugs 1472-4472 9 800 2008-07-01 Morphine-6-glucuronide, an active morphine metabolite for the potential treatment of post-operative pain http://www.biomedcentral.com/1472-4472/9/786 GP Joshi Current Opinion in Investigational Drugs 2008, 9:786-799 2008-07-01 doi:10.1186/cd-921660 Current Opinion in Investigational Drugs 1472-4472 9 786 2008-07-01 Casopitant, a neurokinin-1 receptor antagonist with anti-emetic and antinausea activities http://www.biomedcentral.com/1472-4472/9/774 RM Navari Current Opinion in Investigational Drugs 2008, 9:774-785 2008-07-01 doi:10.1186/cd-921659 Current Opinion in Investigational Drugs 1472-4472 9 774 2008-07-01 Estrogen receptor beta agonists in neurobehavioral investigations http://www.biomedcentral.com/1472-4472/9/760 E Choleris, AE Clipperton, A Phan and M Kavaliers Current Opinion in Investigational Drugs 2008, 9:760-773 2008-07-01 doi:10.1186/cd-921658 Current Opinion in Investigational Drugs 1472-4472 9 760 2008-07-01 The role of sildenafil in the treatment of stroke http://www.biomedcentral.com/1472-4472/9/754 MM Bednar Current Opinion in Investigational Drugs 2008, 9:754-759 2008-07-01 doi:10.1186/cd-921657 Current Opinion in Investigational Drugs 1472-4472 9 754 2008-07-01 PDEs as drug targets for CNS immune disorders http://www.biomedcentral.com/1472-4472/9/744 ALO Hebb and HA Robertson Current Opinion in Investigational Drugs 2008, 9:744-753 2008-07-01 doi:10.1186/cd-921655 Current Opinion in Investigational Drugs 1472-4472 9 744 2008-07-01 The emerging role of docosahexaenoic acid in neuroinflammation http://www.biomedcentral.com/1472-4472/9/735 SK Orr and RP Bazinet Current Opinion in Investigational Drugs 2008, 9:735-743 2008-07-01 doi:10.1186/cd-921654 Current Opinion in Investigational Drugs 1472-4472 9 735 2008-07-01 Neuroimmune interactions and pain: Focus on glial-modulating targets http://www.biomedcentral.com/1472-4472/9/726 EA Romero-Sandoval, RJ Horvath and JA DeLeo Current Opinion in Investigational Drugs 2008, 9:726-734 2008-07-01 doi:10.1186/cd-921653 Current Opinion in Investigational Drugs 1472-4472 9 726 2008-07-01 Homomeric and heteromeric P2X3 receptors in peripheral sensory neurons http://www.biomedcentral.com/1472-4472/9/716 J-D Brederson and MF Jarvis Current Opinion in Investigational Drugs 2008, 9:716-725 2008-07-01 doi:10.1186/cd-921645 Current Opinion in Investigational Drugs 1472-4472 9 716 2008-07-01 Linking calcium-channel isoforms to potential therapies http://www.biomedcentral.com/1472-4472/9/707 F Belardetti and GW Zamponi Current Opinion in Investigational Drugs 2008, 9:707-715 2008-07-01 doi:10.1186/cd-921642 Current Opinion in Investigational Drugs 1472-4472 9 707 2008-07-01 Cognitive endpoints as disease biomarkers: Optimizing the congruency of preclinical models to the clinic http://www.biomedcentral.com/1472-4472/9/696 M Day, F Balci, HI Wan, GB Fox, JL Rutkowski and G Feuerstein Current Opinion in Investigational Drugs 2008, 9:696-706 2008-07-01 doi:10.1186/cd-921641 Current Opinion in Investigational Drugs 1472-4472 9 696 2008-07-01 Novel analgesic development: From target to patient or patient to target? http://www.biomedcentral.com/1472-4472/9/694 CJ Woolf Current Opinion in Investigational Drugs 2008, 9:694-695 2008-07-01 doi:10.1186/cd-921640 Current Opinion in Investigational Drugs 1472-4472 9 694 2008-07-01 Patent alert http://www.biomedcentral.com/1472-4472/9/684 HAM Mucke, P Norman, C Whelan and C Yeates Current Opinion in Investigational Drugs 2008, 9:684-693 2008-07-01 doi:10.1186/cd-921639 Current Opinion in Investigational Drugs 1472-4472 9 684 2008-07-01 Patent selection http://www.biomedcentral.com/1472-4472/9/681 HAM Mucke Current Opinion in Investigational Drugs 2008, 9:681-683 2008-07-01 doi:10.1186/cd-921638 Current Opinion in Investigational Drugs 1472-4472 9 681 2008-07-01 Paper alert http://www.biomedcentral.com/1472-4472/9/673 SA Antoniu, M Daneshtalab, S Doggrell, MJ Elices, RE Hurst and M Williams Current Opinion in Investigational Drugs 2008, 9:673-680 2008-07-01 doi:10.1186/cd-921636 Current Opinion in Investigational Drugs 1472-4472 9 673 2008-07-01 Axitinib, a novel anti-angiogenic drug with promising activity in various solid tumors http://www.biomedcentral.com/1472-4472/9/658 TK Choueiri Current Opinion in Investigational Drugs 2008, 9:658-671 2008-05-28 doi:10.1186/cd-910557 Current Opinion in Investigational Drugs 1472-4472 9 658 2008-05-28